Source of new products for the pharmaceutical industry
Supported by FDA set of regulatory guidelinesFROM FARM TO PHARM®
Targeted Therapies
Devonian develops prescription drugs that target multiple cellular pathways and regulate genes linked to inflammatory autoimmune diseases, with a focus on gastrointestinal, dermatological, and hepatologic conditions.
Subscribe to get corporate news and press releases
A CLINICAL STAGE
PHARMACEUTICAL COMPANY
Focused on rapidly expanding area of Inflammatory diseases
TECHNOLOGY
Based on a broad-based platform originating from over fifteen years of research.
PRODUCTS
Novel Therapeutics for dermatological applications.
PIPELINE
Advanced stage products.
INVESTORS
Focused on generating greater Shareholder value.